Publications by authors named "Niladri Ghosal"
Despite the high cancer burden in low-middle-income-countries, medical students often have inadequate exposure to oncology. This may contribute to reduced interest in pursuing training in the field. The second ecancer TMC Oncology Congress at Kolkata on 30th September and 1st October 2023 was planned primarily to introduce undergraduate medical and allied health science students to oncology.
View Article and Find Full Text PDFBackground: Advances in cancer management have been associated with an increased incidence of emergency presentations with disease- or treatment-related complications.
Objective: This study aimed to measure the ability of patients and members of their social network to complete checklists for complications of systemic treatment for cancer and examine the impact on patient-centered and health-economic outcomes.
Methods: A prospective interventional cohort study was performed to assess the impact of a smartphone app used by patients undergoing systemic cancer therapy and members of their network to monitor for common complications.
Background: Medical decisions made by oncology clinicians have serious implications, even when made collaboratively with the patient. Clinicians often use the Eastern Clinical Oncology Group (ECOG) performance status (PS) scores to help them make treatment-related decisions.
Methods: The current study explores the variability of the ECOG score when applied to 12 predetermined specially designed clinical case vignettes presented to a group of oncology clinicians ( = 72).
Phase II study of cisplatin and imatinib in advanced salivary adenoid cystic carcinoma.
Br J Oral Maxillofac Surg
October 2011
Article Synopsis
- Patients with adenoid cystic carcinoma of the salivary glands often have high levels of KIT expression, but treatment options are limited for advanced cases.
- A phase II clinical trial was conducted with 28 patients using a treatment regimen of imatinib and cisplatin, which included an initial phase with imatinib followed by a combination of the two drugs.
- Results showed that three patients had a partial response, five had a response on PET scans, and 19 experienced disease stabilization, with a median overall survival of 35 months, indicating that this treatment may help manage the disease.